CL2014003561A1 - Ácido nucleico infeccioso de virus torque teno porcino (pttv) que comprende secuencia que codifica un pttv infeccioso con una secuencia genómica de pttv 1b-va; ácido nucleico, plásmido y célula hospedera que la comprenden; pttv infeccioso no virulento; vacuna. - Google Patents

Ácido nucleico infeccioso de virus torque teno porcino (pttv) que comprende secuencia que codifica un pttv infeccioso con una secuencia genómica de pttv 1b-va; ácido nucleico, plásmido y célula hospedera que la comprenden; pttv infeccioso no virulento; vacuna.

Info

Publication number
CL2014003561A1
CL2014003561A1 CL2014003561A CL2014003561A CL2014003561A1 CL 2014003561 A1 CL2014003561 A1 CL 2014003561A1 CL 2014003561 A CL2014003561 A CL 2014003561A CL 2014003561 A CL2014003561 A CL 2014003561A CL 2014003561 A1 CL2014003561 A1 CL 2014003561A1
Authority
CL
Chile
Prior art keywords
pttv
infectious
nucleic acid
virulent
porcine
Prior art date
Application number
CL2014003561A
Other languages
English (en)
Inventor
Yaowei Huang
Xiang-Jin Meng
Original Assignee
Virginia Tech Intell Prop
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virginia Tech Intell Prop filed Critical Virginia Tech Intell Prop
Publication of CL2014003561A1 publication Critical patent/CL2014003561A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/00021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/00022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/00034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01—DNA viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/085—Picornaviridae, e.g. coxsackie virus, echovirus, enterovirus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Analytical Chemistry (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
CL2014003561A 2009-08-21 2014-12-29 Ácido nucleico infeccioso de virus torque teno porcino (pttv) que comprende secuencia que codifica un pttv infeccioso con una secuencia genómica de pttv 1b-va; ácido nucleico, plásmido y célula hospedera que la comprenden; pttv infeccioso no virulento; vacuna. CL2014003561A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23583309P 2009-08-21 2009-08-21
US31651910P 2010-03-23 2010-03-23
US12/861,378 US9228242B2 (en) 2009-08-21 2010-08-23 Porcine torque teno virus vaccines and diagnosis

Publications (1)

Publication Number Publication Date
CL2014003561A1 true CL2014003561A1 (es) 2015-04-24

Family

ID=43605547

Family Applications (4)

Application Number Title Priority Date Filing Date
CL2012000452A CL2012000452A1 (es) 2009-08-21 2012-02-22 Acido nucleico infeccioso de virus torque teno porcino (pttv), que comprende secuencia que codifica un pttv infeccioso con una secuencia genomica de pttv 1a-va; acido nucleico, plasmido y celula hospedera que la comprenden; pttv infeccioso no virulento; vacuna.
CL2014003562A CL2014003562A1 (es) 2009-08-21 2014-12-29 Acido nucleico infeccioso de virus torque teno porcino (pttv) que comprende secuencia que codifica un pttv infeccioso con una secuencia genómica de pttv 2b-va; acido nucleico, plásmido y célula hospedera que la comprenden; pttv infeccioso no virulento; vacuna
CL2014003561A CL2014003561A1 (es) 2009-08-21 2014-12-29 Ácido nucleico infeccioso de virus torque teno porcino (pttv) que comprende secuencia que codifica un pttv infeccioso con una secuencia genómica de pttv 1b-va; ácido nucleico, plásmido y célula hospedera que la comprenden; pttv infeccioso no virulento; vacuna.
CL2014003563A CL2014003563A1 (es) 2009-08-21 2014-12-29 Acido nucleico infeccioso de virus torque teno porcino (pttv) que comprende secuencia que codifica un pttv infeccioso con una secuencia genómica de pttv 2c-va; acido nucleico, plásmido y célula hospedera que la comprenden; pttv infeccioso no virulento; vacuna

Family Applications Before (2)

Application Number Title Priority Date Filing Date
CL2012000452A CL2012000452A1 (es) 2009-08-21 2012-02-22 Acido nucleico infeccioso de virus torque teno porcino (pttv), que comprende secuencia que codifica un pttv infeccioso con una secuencia genomica de pttv 1a-va; acido nucleico, plasmido y celula hospedera que la comprenden; pttv infeccioso no virulento; vacuna.
CL2014003562A CL2014003562A1 (es) 2009-08-21 2014-12-29 Acido nucleico infeccioso de virus torque teno porcino (pttv) que comprende secuencia que codifica un pttv infeccioso con una secuencia genómica de pttv 2b-va; acido nucleico, plásmido y célula hospedera que la comprenden; pttv infeccioso no virulento; vacuna

Family Applications After (1)

Application Number Title Priority Date Filing Date
CL2014003563A CL2014003563A1 (es) 2009-08-21 2014-12-29 Acido nucleico infeccioso de virus torque teno porcino (pttv) que comprende secuencia que codifica un pttv infeccioso con una secuencia genómica de pttv 2c-va; acido nucleico, plásmido y célula hospedera que la comprenden; pttv infeccioso no virulento; vacuna

Country Status (19)

Country Link
US (2) US9228242B2 (es)
EP (2) EP2467484A4 (es)
JP (3) JP6002036B2 (es)
KR (3) KR101640062B1 (es)
CN (2) CN102712930B (es)
AU (1) AU2010292848B2 (es)
BR (1) BR112012003844B1 (es)
CA (1) CA2771771C (es)
CL (4) CL2012000452A1 (es)
CO (1) CO6531416A2 (es)
ES (1) ES2767781T3 (es)
HK (1) HK1249111A1 (es)
IN (1) IN2012DN02305A (es)
MX (1) MX344015B (es)
PL (1) PL2851428T3 (es)
RU (1) RU2553223C2 (es)
SG (1) SG178512A1 (es)
WO (1) WO2011031438A2 (es)
ZA (1) ZA201201949B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102712930B (zh) 2009-08-21 2017-06-13 弗吉尼亚理工大学知识产权公司 猪细环病毒的疫苗和诊断
EP2530170A1 (en) * 2011-05-31 2012-12-05 Intervet International BV Torque Teno virus diagnostics
CN102590503B (zh) * 2012-01-20 2015-02-25 四川农业大学 一种猪细环病毒ⅱ型抗体间接阻断elisa检测试剂盒
CN103376317B (zh) * 2012-04-12 2015-11-18 徐超 不同疫苗适用性与经济性的现场判定方法
EP2653562A1 (en) * 2012-04-20 2013-10-23 Institut Pasteur Anellovirus genome quantification as a biomarker of immune suppression
CN102998453B (zh) * 2012-11-23 2014-10-08 广东海大畜牧兽医研究院有限公司 一种猪Ⅰ型细环病毒TTSuV1抗体间接ELISA诊断试剂盒及其制备方法
CN103014056B (zh) * 2012-11-23 2014-12-10 广东海大畜牧兽医研究院有限公司 一种猪Ⅱ型细环病毒TTSuV2-ORF1截短蛋白的酵母表达及应用
CN103235121B (zh) * 2013-03-18 2015-08-05 江苏省农业科学院 一种检测猪输血传播病毒2型抗体的间接elisa试剂盒
JP7088835B2 (ja) * 2015-10-16 2022-06-21 カンザス ステイト ユニバーシティ リサーチ ファウンデーション ブタサーコウイルス３型免疫原性組成物、その製造方法、およびその使用方法
CN107604098A (zh) * 2017-11-03 2018-01-19 福建省农业科学院畜牧兽医研究所 用于检测鸽TTV的EvaGreen实时荧光定量PCR引物及试剂盒
CN109061161B (zh) * 2018-11-14 2019-02-15 湖南省植物保护研究所 用于检测辣椒脉黄病毒的检测试剂盒及其应用
BR112022025190A2 (pt) * 2020-06-12 2023-03-07 Flagship Pioneering Innovations V Inc Construtos de anellovirus em tandem
MX2023007643A (es) * 2020-12-23 2023-09-04 Flagship Pioneering Innovations V Inc Ensamblaje in vitro de cápsides de anellovirus que encierran arn.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1061377C (zh) * 1996-12-13 2001-01-31 中国预防医学科学院病毒学研究所 能用于包装重组腺病毒伴随病毒的单疱病毒载体及其用途
CN1704119A (zh) * 2004-05-28 2005-12-07 上海佳牧生物制品有限公司 猪细小病毒病油乳剂灭活疫苗
US20090269282A1 (en) 2006-10-05 2009-10-29 Ellis John A Methods for treating, preventing and diagnosing procine ttv infection
BRPI0920248A2 (pt) * 2008-10-16 2016-01-05 Pfizer isolados e composicoes do virus torque teno(ttv)
CN102712930B (zh) 2009-08-21 2017-06-13 弗吉尼亚理工大学知识产权公司 猪细环病毒的疫苗和诊断

Also Published As

Publication number Publication date
CL2012000452A1 (es) 2013-07-05
CN102712930A (zh) 2012-10-03
BR112012003844A2 (pt) 2016-11-16
CL2014003562A1 (es) 2015-04-24
MX2012002273A (es) 2012-09-07
RU2012110303A (ru) 2013-09-27
HK1249111A1 (zh) 2018-10-26
BR112012003844B1 (pt) 2021-05-04
AU2010292848B2 (en) 2014-11-27
KR101640062B1 (ko) 2016-07-18
US9897605B2 (en) 2018-02-20
MX344015B (es) 2016-12-02
JP2013502229A (ja) 2013-01-24
CN102712930B (zh) 2017-06-13
JP2015221819A (ja) 2015-12-10
CO6531416A2 (es) 2012-09-28
EP2851428A3 (en) 2015-04-29
JP6126176B2 (ja) 2017-05-10
KR20140110101A (ko) 2014-09-16
WO2011031438A2 (en) 2011-03-17
US20110045019A1 (en) 2011-02-24
EP2851428B1 (en) 2019-04-10
KR20140127903A (ko) 2014-11-04
CL2014003563A1 (es) 2015-04-17
PL2851428T3 (pl) 2019-12-31
WO2011031438A3 (en) 2011-06-30
JP6002036B2 (ja) 2016-10-05
KR101721090B1 (ko) 2017-03-29
US20160216263A1 (en) 2016-07-28
CA2771771A1 (en) 2011-03-17
SG178512A1 (en) 2012-03-29
IN2012DN02305A (es) 2015-08-21
ES2767781T3 (es) 2020-06-18
US9228242B2 (en) 2016-01-05
AU2010292848A1 (en) 2012-04-12
WO2011031438A9 (en) 2011-08-18
EP2467484A4 (en) 2013-06-12
ZA201201949B (en) 2013-05-29
KR20120063489A (ko) 2012-06-15
CN107522775A (zh) 2017-12-29
EP2467484A2 (en) 2012-06-27
JP2017171663A (ja) 2017-09-28
CA2771771C (en) 2018-09-11
EP2851428A2 (en) 2015-03-25
RU2553223C2 (ru) 2015-06-10

Similar Documents

Publication Publication Date Title
CL2014003561A1 (es) Ácido nucleico infeccioso de virus torque teno porcino (pttv) que comprende secuencia que codifica un pttv infeccioso con una secuencia genómica de pttv 1b-va; ácido nucleico, plásmido y célula hospedera que la comprenden; pttv infeccioso no virulento; vacuna.
CL2012003373A1 (es) Huesped recombinante que comprende uno o mas genes de la biosintesis de esteviol; ácido nucleico aislado que comprende dichos genes; metodo para producir esteviol, un glucósido de esteviol o una composicion de glucósido de esteviol; cepa de saccharomyces recombinante; composicion de glucósido de esteviol.
PH12018501602A1 (en) Subunit immersion vaccines for fish
EA201791343A1 (ru) Композиции и способы для конструирования вирусного генома in vitro
BR112014009565A2 (pt) vírus da doença de marek não patogênico recombinante, ácido nucleico recombinante, vacina, e, método para ajudar na proteção de um frango contra vírus
BRPI0814459A2 (pt) Célula de inseto, método para produzir um vírion parvoviral recombinante em uma célula de inserto, e, construção de ácido nucleico.
HK1123055A1 (en) Hepatitis c virus nucleic acid vaccine
BRPI0811499A2 (pt) Métodos para purificar um vírus ou antígeno viral, e para preparar uma vacina contra um vírus ou antígeno viral.
MX2013010620A (es) Adenovirus de aves del serotipo 4 (fadv-4) no patogénico y vector viral del mismo.
DK2519266T3 (da) Infektiøse DNA vacciner mod Chikungunya virus
EP2498814A4 (en) CONSUMER PROTEINS FOR MOUSE AND CLAUSE DISEASE VIRUSES, VACCINATING SEQUENCES AND VACCINES MANUFACTURED THEREFROM
UA108902C2 (uk) Вірус північноамериканського репродуктивного та респіраторного синдрому свиней (prrs) та його застосування
EP2328575A4 (en) NOVEL NORMALIZED COMPOSITION, METHOD OF MANUFACTURE, AND USE FOR RESOLVING RNA VIRUS INFECTION
CL2008000249A1 (es) Uso de una molecula de acido nucleico que codifica al menos un polipeptido e2 del papilomavirus, un vector o una particula virica infecciosa que la comprenda para tratar una infeccion permanente por papilomavirus causada por al menos un papilomavirus
ZA201306009B (en) Nucleic acid molecule encoding hepatitis b virus core protein and vaccine comprising the same
HK1165694A1 (zh) 密碼子優化的乙型肝炎病毒核心抗原
WO2009115917A3 (en) Improvements in preparation of influenza virus vaccine antigens
CL2015001803A1 (es) Composición inmunogénica que comprende cepas del virus del oeste del nilo muerto o inactivado o cualquier antígeno del mismo; y método para disminuir síntomas clínicos asociados a infección por dicho virus en animales (div. sol. n° 445-11)
WO2011014416A3 (en) High yield yellow fever virus strain with increased propagation in cells
WO2007082734A3 (en) Influenza vaccine
WO2013052095A3 (en) Vaccine
AR067439A1 (es) Virus quimericos antigenicos de virus de encefalitis de st. louis/virus dengue tipo 4
ECSP12012131A (es) Método, plasmideo y composición para inducir una respuesta inmune contra virus de la dengue basado en vacunas de adn y virus quiméricos
WO2012116253A3 (en) Recombinant mumps virus vaccine
DK2459557T3 (da) Cykliske (aza)indolizincarboxamider, deres fremstilling og deres anvendelse som lægemidler